发明名称 |
Macrocyclic indole derivatives useful as hepatitis C virus inhibitors |
摘要 |
Inhibitors of HCV replication of formula (I);
including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R1, R2, R4, R5, R6 and R7 have the meaning defined in the claims.
;The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy. |
申请公布号 |
US9427440(B2) |
申请公布日期 |
2016.08.30 |
申请号 |
US201313836168 |
申请日期 |
2013.03.15 |
申请人 |
Janssen Sciences Ireland UC |
发明人 |
Vendeville Sandrine Marie Helene;Raboisson Pierre Jean-Marie Bernard;Lin Tse-I;Tahri Abdellah;Amssoms Katie Ingrid Eduard |
分类号 |
A61K31/55;C07D513/14;C07D513/18;C07D515/18;A61K45/06;C07D513/22 |
主分类号 |
A61K31/55 |
代理机构 |
|
代理人 |
Kamage Andrea Jo |
主权项 |
1. A method for inhibiting HCV replication, comprising administering to a subject in need thereof a compound of Formula (I) or a stereochemically isomeric form, N-oxide, salt, hydrate, or solvate thereof, wherein:
R1 is a bivalent chain selected from each R3 is independently selected from the group comprising hydrogen, C1-4alkyl and C3-5cycloalkyl;a is 3, 4, 5 or 6;each b is independently 1 or 2;c is 1 or 2;macrocycle A has 14 to 18 member atoms;each R2 is independently hydrogen, halo or C1-4alkoxy;R4 and R5 are hydrogen or R4 and R5 together form a double bond or a methylene group to form a fused cyclopropyl;R6 is hydrogen or methyl; andR7 is a C3-7cycloalkyl optionally substituted with halo. |
地址 |
Little Island, County Cork IE |